This trial has been completed.

Condition fetal heart echocardiography by five dimensional ultrasound
Sponsor Ain Shams University
Start date December 2015
End date August 2016
Trial size 90 participants
Trial identifier NCT02643199, 5D Echocardiography


The aim of the study to evaluate Five-Dimensional Ultrasound in automated assessment of the fetal heart from 34-36 weeks of gestation.

United States No locations recruiting
Other countries No locations recruiting

Study Design

Observational model cohort
Time perspective prospective

Primary Outcomes

folliclulometry by Five-Dimensional Ultrasound and Two-Dimensional Ultrasound measurement In controlled ovarian stimulation
time frame: 10 months

Eligibility Criteria

Female participants from 18 years up to 38 years old.

Inclusion Criteria: 1. Singleton pregnancy. 2. Gestational age at 34-36 weeks as determined be date and last menstrual period. 3. Normal Amniotic Fluid Index. Exclusion Criteria: 1. Multiple pregnancies. 2. Oligohydramnios or Polyhydramnios (AFI > 95th percentile or < 5th percentile). 3. Obese patient, BMI > 30 4. Intrauterine growth restriction. 5. Fetal spine between the 11- and 1- O'clock positions due to possibility of shadowing from ribs or spine

Additional Information

Official title Automated Fetal Heart Echocardiography by Five-Dimensional Ultrasound in the Third Trimester of Pregnancy
Description This is a Prospective pilot study that will be performed at the Fetal Care Unit at Ain Shams University Maternity Hospital. Ninety pregnant women will be recruited from the Fetal Care Unit who will fulfill the inclusion criteria. They will be counseled to be included into the study. All cases will be subjected to: 1. Full history taking including patient's age, parity, last menstrual period, estimated gestational age by dates, past history of medical disorders, clinical examinations (General and abdominal). 2. Two-Dimensional Ultrasound and Five-Dimensional Ultrasound will be done for all cases for assessment of fetal Heart. - 90 consecutive patients will undergo 2D fetal echocardiography by one observer - Then they will undergo blindly Five-Dimensional fetal echocardiography by another observer - The data collected will be compared to evaluate the accuracy of Five-Dimensional US in fetal heart assessment.
Trial information was received from ClinicalTrials.gov and was last updated in November 2016.
Information provided to ClinicalTrials.gov by Ain Shams University.